Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

2013 Statement on Human Papillomavirus DNA Test Utilization

11 Mar 2014

Abstract excerpt

In 2009, the Cytopathology Education and Technology Consortium issued a statement on human papillomavirus (HPV) DNA test utilization that was published in multiple journals.1 This statement was a concise summary of the clinical indications for high-risk or oncogenic HPV testing based on guidelines from the American Society for Colposcopy and Cervical Pathology (ASCCP) and the American Cancer Society (ACS)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cervical Cancer and HPV Research
Share to Global Cancer Incidence and Screening

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 24619744
DOI: 10.1309/ajcpkxbqlwoj4zub

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

2013 Statement on Human Papillomavirus DNA Test UtilizationPMID 24619744Read ↗

High-risk HPV DNA testing and HPV-16/18 genotyping: what is the clinical application?Semantic proximity Read ↗

Retrospective analysis of HPV infection: Cotesting and HPV genotyping in cervical cancer screening within a large academic health care system.Semantic proximity Read ↗

Human Papillomavirus Testing MethodsSemantic proximity Read ↗

Colposcopic Biopsy Findings in ASCUS or Normal Cervical Cytology Patients with High-Risk HPV PositivitySemantic proximity Read ↗

Human papillomavirus testing and reporting rates in 2012: results of a College of American Pathologists national survey.Semantic proximity Read ↗

Extended HPV genotyping and dual stain for the triage of primary HPV screen-positive cases: Practical guidance for the cytopathology laboratory.Semantic proximity Read ↗

Triage options for positive high-risk HPV results from HPV-based cervical cancer screening: a review of the potential alternatives to Papanicolaou test cytology.Semantic proximity Read ↗

Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.Semantic proximity Read ↗

Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV+ cytology-negative results.Semantic proximity Read ↗

Human Papillomavirus and Cervical Cancer ScreeningSemantic proximity Read ↗

Chapter 12: Human Papillomavirus TechnologiesSemantic proximity Read ↗

Moving forward-the 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors and beyond: implications and suggestions for laboratories.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.